| HOME >> BIOLOGY >> TECHNOLOGY |
Cash provided by (used in):
Operating activities:
Loss for the period (2,584,081) (2,306,695) (35,117,714)
Items not involving cash:
Amortization of:
Facilities and equipment 92,314 81,415 1,371,185
Deferred costs - - 55,055
Leasehold inducements (10,371) (10,372) (66,524)
Loss on disposal of equipment - - 23,532
Write-off of leasehold
improvements - - 86,349
Leasehold inducement - - 89,148
Non-cash stock-based
compensation 170,077 210,584 1,800,678
Accretion of convertible
debentures - - 429,905
Loss on extinguishment of debt - - 782,143
Services received for common
shares - - 400,024
Write-off of investment - - 20,000
Interest expense paid in
common shares - - 140,032
Change in non-cash operating
working capital items (784,438) 671,390 4,279,109
-----------------------------------------------------------------------
(3,116,499) (1,353,678) (25,707,078)
Financing activities:
Issue of shares, warrants and
units, net of issuance costs - - 38,281,778
Issuance of convertible bridge
loan, net - - 2,196,619
Repayment of convertible bridge
loan, including costs
'/>"/>
| SOURCE ARIUS Research Inc. Copyright©2008 PR Newswire. All rights reserved |